CS
ZYME icon

Credit Suisse’s Zymeworks ZYME Stock Holding History

Credit Suisse’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$19.9M Sell
1,895,757
-407,864
-18% -$4.53M 0.02% 633
2023
Q4 		$24M Sell
2,303,621
-185,555
-7% -$1.48M 0.02% 615
2023
Q3 		$15.9M Sell
2,489,176
-20,064
-0.8% -$148K 0.02% 712
2023
Q2 		$21.7M Buy
2,509,240
+23,955
+1% +$214K 0.02% 640
2023
Q1 		$22.5M Buy
2,485,285
+46,190
+2% +$403K 0.02% 639
2022
Q4 		$19.2M Sell
2,439,095
-1,277
-0.1% -$8.97K 0.02% 681
2022
Q3 		$15M Sell
2,440,372
-2,625
-0.1% -$15.8K 0.02% 753
2022
Q2 		$12.9M Sell
2,442,997
-32,005
-1% -$194K 0.01% 843
2022
Q1 		$16.2M Buy
2,475,002
+11,027
+0.4% +$98.3K 0.01% 843
2021
Q4 		$40.4M Buy
2,463,975
+117,457
+5% +$2.45M 0.02% 742
2021
Q3 		$68.1M Buy
2,346,518
+158
+0% +$5.25K 0.04% 518
2021
Q2 		$84.2M Buy
2,346,360
+54,871
+2% +$1.74M 0.04% 449
2021
Q1 		$72.4M Buy
2,291,489
+459,928
+25% +$18.7M 0.04% 558
2020
Q4 		$86.6M Buy
1,831,561
+112,843
+7% +$5.24M 0.04% 474
2020
Q3 		$80.1M Buy
1,718,718
+400,632
+30% +$13.8M 0.05% 420
2020
Q2 		$47.5M Buy
1,318,086
+413,080
+46% +$15.2M 0.03% 558
2020
Q1 		$32.1M Buy
905,006
+814,101
+896% +$33.3M 0.03% 608
2019
Q4 		$4.13M Buy
90,905
+74,007
+438% +$2.69M ﹤0.01% 2015
2019
Q3 		$419K Buy
+16,898
New +$423K ﹤0.01% 3525

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Credit Suisse's ZYME Position: Q1 2024 in Review

Credit Suisse reduced its Zymeworks (ZYME) stake by 18% in Q1 2024, selling an estimated $4.53M and leaving 1,895,757 shares worth $19.9M. The position accounts for 0.02% of the portfolio, ranked #633.

Credit Suisse first reported a position in ZYME in Q3 2019 and has held it in 19 quarters since. The position peaked at $86.6M in Q4 2020. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Credit Suisse held 1,895,757 shares of Zymeworks worth $19.9M as of Q1 2024.
  • Credit Suisse sold 407,864 Zymeworks shares in Q1 2024, an estimated $4.53M.
  • Zymeworks made up 0.02% of Credit Suisse's portfolio in Q1 2024, its #633 holding.
  • Credit Suisse first reported a position in Zymeworks in Q3 2019 and has held it in 19 quarters since.
  • Credit Suisse's Zymeworks position peaked at $86.6M in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.